PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 79 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 44.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $211,000 | -22.4% | 28,300 | -37.8% | 0.02% | -21.7% |
| Q1 2015 | $272,000 | -34.9% | 45,500 | -17.7% | 0.02% | -36.1% |
| Q4 2014 | $418,000 | +132.2% | 55,300 | +25.4% | 0.04% | +71.4% |
| Q1 2014 | $180,000 | +195.1% | 44,100 | +261.5% | 0.02% | +200.0% |
| Q3 2013 | $61,000 | -17.6% | 12,200 | -26.9% | 0.01% | -46.2% |
| Q2 2013 | $74,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 1,255,000 | $5,823,000 | 1.12% |
| Phocas Financial Corp. | 1,146,292 | $5,319,000 | 0.54% |
| Worth Venture Partners, LLC | 138,357 | $641,000 | 0.36% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,293,179 | $10,640,000 | 0.34% |
| Monashee Investment Management LLC | 240,000 | $1,114,000 | 0.26% |
| BKS ADVISORS, LLC | 118,587 | $550,000 | 0.22% |
| PINNACLE ASSOCIATES LTD | 1,418,391 | $6,581,000 | 0.15% |
| FARALLON CAPITAL MANAGEMENT LLC | 4,200,820 | $19,492,000 | 0.15% |
| Fosun International Ltd | 472,580 | $2,174,000 | 0.14% |
| CARILLON TOWER ADVISERS, INC. | 3,948,024 | $18,318,000 | 0.13% |